RE:RE:RE:Li Ka Shing
Does seem a bit surreal to be priced so low compared with potential. I am not a big investor person so others can perhaps weigh in on factors. My amateur thoughts:
- most of my other biotechs are regularly participating in various investor health meetings (e.g. Wainwright conf) whereas TLT has no presence in any of them. My guess is that they don't invite you if not on NASDAQ.
- does being on venture and OTC exchanges give you a poor reputation? I'm guessing it doesn't help pull people in.
- low price point makes some disrespect the stock. Saw someone diss TLT on Stocktwits as "that 14 cent company".
- I wonder what the ratio of long holders are to the rest. Most of us here seem to believe in the science and have bought and held (I'm guessing). The insiders have also held. As such, it seems to be the rest of the people that determine the price right now. Some days the price can shift on just 25,000 dollars worith of shares. Makes the price seem low but perhaps it is the people shuffling shares around that are determining the price these days, while the rest of us just watch from the sidelines.
Other thoughts?